Impact of molecular profiling on survival in patients with advanced biliary tract cancers

被引：1
|
作者：
Antoun, L. [1 ]
Deneche, I. [1 ]
Boileve, A. [2 ]
Tarabay, A. [2 ]
Rouleau, E. [1 ]
El Rawadi, E. [1 ]
Eid, R. [1 ]
Lacroix, L. [1 ]
Valery, M. [1 ]
Boige, V. [1 ]
Dartigues, P. [1 ]
Bani, M. [1 ]
Smolenschi, C. [2 ]
Scoazec, J. [1 ]
Ducreux, M. [1 ]
Hollebecque, A. [2 ]
Malka, D. [3 ]
机构：
[1] Gustave Roussy, Villejuif, France
[2] Gustave Roussy, Dept Med Oncol, Villejuif, France
[3] Inst Mutualiste Montsouris, Paris, France
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.04.476
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SO-4
引用
收藏
页码：S163 / S163
页数：1
相关论文
共 50 条
  • [21] P Palliative management of malignant biliary obstruction in patients with advanced biliary tract cancers
    Berrad, S.
    Oualla, K.
    Nouikh, I.
    Frraichi, H.
    Messoudi, K.
    Mellas, N.
    Benbrahim, Z.
    ANNALS OF ONCOLOGY, 2019, 30
  • [22] MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers
    Niger, Monica
    Nichetti, Federico
    Casadei-Gardini, Andrea
    Morano, Federica
    Pircher, Chiara
    Tamborini, Elena
    Perrone, Federica
    Canale, Matteo
    Lipka, Daniel B.
    Vingiani, Andrea
    Agnelli, Luca
    Dobberkau, Anna
    Huellein, Jennifer
    Korell, Felix
    Heilig, Christoph E.
    Pusceddu, Sara
    Corti, Francesca
    Droz, Michele
    Ulivi, Paola
    Prisciandaro, Michele
    Antista, Maria
    Bini, Marta
    Cattaneo, Laura
    Milione, Massimo
    Glimm, Hanno
    Koehler, Bruno C.
    Pruneri, Giancarlo
    Huebschmann, Daniel
    Froehling, Stefan
    Mazzaferro, Vincenzo
    Pietrantonio, Filippo
    Di Bartolomeo, Maria
    de Braud, Filippo
    MOLECULAR ONCOLOGY, 2022, 16 (14) : 2733 - 2746
  • [23] FOLFIRI in advanced biliary tract cancers.
    Mizrahi, Jonathan
    Gunchick, Valerie
    Mody, Kabir
    Xiao, Lianchun
    Surapaneni, Phani Keerthi
    Shroff, Rachna T.
    Sahai, Vaibhav
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [24] Nanoliposomal irinotecan in advanced biliary tract cancers
    Malka, David
    Colle, Raphael
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (08): : 683 - 684
  • [25] Gemcitabine treatment for advanced biliary tract cancers
    Fujita, Tsunenori
    Ajiki, Tetsuo
    Matsumoto, Ippei
    Hirata, Kenro
    Takase, Shiro
    Kamigaki, Takashi
    Shinzeki, Makoto
    Fujino, Yasuhiro
    Kuroda, Yeshikazu
    Ku, Yonson
    GASTROENTEROLOGY, 2007, 132 (04) : A202 - A202
  • [26] mTOR Inhibitors in Advanced Biliary Tract Cancers
    Wu, Chao-En
    Chen, Ming-Huang
    Yeh, Chun-Nan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (03)
  • [27] Continuum of care for advanced biliary tract cancers
    Vienot, Angelique
    Neuzillet, Cindy
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2020, 44 (06) : 810 - 824
  • [28] Trends in Receipt of Adjuvant Chemotherapy and Impact on Survival in Resected Biliary Tract Cancers
    Rhodin, Kristen E.
    Liu, Annie
    Bartholomew, Alex
    Kramer, Ryan
    Parameswaran, Anika
    Uronis, Hope
    Strickler, John
    Hsu, David
    Morse, Michael A.
    Shah, Kevin N. N.
    Herbert, Garth
    Zani, Sabino
    Nussbaum, Daniel P.
    Allen, Peter J.
    Lidsky, Michael E.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (8) : 4824 - 4825
  • [29] Biliary tract cancers: Molecular profiling as a too[ for treatment decisions. A literature review
    Rossana, Berardi
    Mario, Scartozzi
    Federica, Freddari
    Michela, Squadroni
    Alfredo, Santinelli
    Italo, Bearzi
    Guidalberto, Fabris
    Stefano, Cascinu
    CANCER TREATMENT REVIEWS, 2006, 32 (05) : 333 - 347
  • [30] Comprehensive molecular characterization of Chinese patients with biliary tract cancers.
    Liu, Daren
    Ye, Dan
    Wu, Jinhong
    Yu, Yangyang
    Zhao, Lele
    Xiao, Mingzhe
    Qi, Chuang
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16153 - E16153
12345